Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets

Detalhes bibliográficos
Autor(a) principal: Wollinger,Wagner
Data de Publicação: 2016
Outros Autores: Silva,Raphael A. da, Nóbrega,Andréa B. da, Lopes,Rosangela S. C., Lopes,Claudio C., Slana,Glaucia B. C. A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of the Brazilian Chemical Society (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532016000500826
Resumo: A suitable and efficient high-performance liquid chromatography (HPLC) method was developed for the simultaneous determination of tuberculostatic isoniazid and its related impurities, isonicotinic acid and isonicotinamide, in oral solid dosage forms. We studied the influence on chromatographic separation of mobile phase parameters, such as pH, ion pairing and ionic strength, as well as column bonded phase and brands. The use of buffer solution pH 6.8:acetonitrile 96:4 (v/v) at 0.8 mL min-1, C18 column (250 × 4.6 mm, 5 µm), allowed proper separation of these ionizable analytes without the need of ion pairing agents. The limit of quantification of the method (0.1 µg mL-1) was suitable for the analysis of impurities. A drug-excipient compatibility study was carried out with the anaytical method proposed in this work and addressed frequent excipients used in isoniazid coated tablets. The dye FD&C blue 2 lake promoted the highest degradation of the tuberculostatic agent.
id SBQ-2_47779233db5d13db901306d74b360fd2
oai_identifier_str oai:scielo:S0103-50532016000500826
network_acronym_str SBQ-2
network_name_str Journal of the Brazilian Chemical Society (Online)
repository_id_str
spelling Assessing Drug-Excipient Interactions in the Formulation of Isoniazid TabletstuberculosisisoniazidHPLCdrug-excipient compatibilityA suitable and efficient high-performance liquid chromatography (HPLC) method was developed for the simultaneous determination of tuberculostatic isoniazid and its related impurities, isonicotinic acid and isonicotinamide, in oral solid dosage forms. We studied the influence on chromatographic separation of mobile phase parameters, such as pH, ion pairing and ionic strength, as well as column bonded phase and brands. The use of buffer solution pH 6.8:acetonitrile 96:4 (v/v) at 0.8 mL min-1, C18 column (250 × 4.6 mm, 5 µm), allowed proper separation of these ionizable analytes without the need of ion pairing agents. The limit of quantification of the method (0.1 µg mL-1) was suitable for the analysis of impurities. A drug-excipient compatibility study was carried out with the anaytical method proposed in this work and addressed frequent excipients used in isoniazid coated tablets. The dye FD&C blue 2 lake promoted the highest degradation of the tuberculostatic agent.Sociedade Brasileira de Química2016-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532016000500826Journal of the Brazilian Chemical Society v.27 n.5 2016reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.5935/0103-5053.20150334info:eu-repo/semantics/openAccessWollinger,WagnerSilva,Raphael A. daNóbrega,Andréa B. daLopes,Rosangela S. C.Lopes,Claudio C.Slana,Glaucia B. C. A.eng2016-05-18T00:00:00Zoai:scielo:S0103-50532016000500826Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2016-05-18T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
title Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
spellingShingle Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
Wollinger,Wagner
tuberculosis
isoniazid
HPLC
drug-excipient compatibility
title_short Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
title_full Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
title_fullStr Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
title_full_unstemmed Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
title_sort Assessing Drug-Excipient Interactions in the Formulation of Isoniazid Tablets
author Wollinger,Wagner
author_facet Wollinger,Wagner
Silva,Raphael A. da
Nóbrega,Andréa B. da
Lopes,Rosangela S. C.
Lopes,Claudio C.
Slana,Glaucia B. C. A.
author_role author
author2 Silva,Raphael A. da
Nóbrega,Andréa B. da
Lopes,Rosangela S. C.
Lopes,Claudio C.
Slana,Glaucia B. C. A.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Wollinger,Wagner
Silva,Raphael A. da
Nóbrega,Andréa B. da
Lopes,Rosangela S. C.
Lopes,Claudio C.
Slana,Glaucia B. C. A.
dc.subject.por.fl_str_mv tuberculosis
isoniazid
HPLC
drug-excipient compatibility
topic tuberculosis
isoniazid
HPLC
drug-excipient compatibility
description A suitable and efficient high-performance liquid chromatography (HPLC) method was developed for the simultaneous determination of tuberculostatic isoniazid and its related impurities, isonicotinic acid and isonicotinamide, in oral solid dosage forms. We studied the influence on chromatographic separation of mobile phase parameters, such as pH, ion pairing and ionic strength, as well as column bonded phase and brands. The use of buffer solution pH 6.8:acetonitrile 96:4 (v/v) at 0.8 mL min-1, C18 column (250 × 4.6 mm, 5 µm), allowed proper separation of these ionizable analytes without the need of ion pairing agents. The limit of quantification of the method (0.1 µg mL-1) was suitable for the analysis of impurities. A drug-excipient compatibility study was carried out with the anaytical method proposed in this work and addressed frequent excipients used in isoniazid coated tablets. The dye FD&C blue 2 lake promoted the highest degradation of the tuberculostatic agent.
publishDate 2016
dc.date.none.fl_str_mv 2016-05-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532016000500826
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532016000500826
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/0103-5053.20150334
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Journal of the Brazilian Chemical Society v.27 n.5 2016
reponame:Journal of the Brazilian Chemical Society (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Journal of the Brazilian Chemical Society (Online)
collection Journal of the Brazilian Chemical Society (Online)
repository.name.fl_str_mv Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv ||office@jbcs.sbq.org.br
_version_ 1750318178313961472